Programmed cell death (PCD) including apoptosis and necrosis are fundamental biological processes that are essential during embryonic development and for homeostasis in somatic tissues. DRs can signal apoptotic cell death when engaged by their cognate ligands[@R8]. This extrinsic death pathway requires the adaptor protein FADD that couples the signal generated by DRs to the apical caspase 8[@R3],[@R9]-[@R10]. The resulting activation of caspase 8 triggers a battery of downstream caspases, leading to apoptosis. Recently, DRs were shown to induce necrosis-like cell death in the presence of caspase inhibitors[@R11]-[@R12]. DR-induced necrosis is blocked in cells lacking the protein serine/threonine kinases RIP1 and RIP3[@R11]-[@R15]. FADD and RIP1 play indispensable roles in development, as *FADD*^−/−^ mice die during midgestation stages[@R4]-[@R5], and *RIP1*^−/−^ mice die at birth[@R16]. Whereas the developmental defect in *RIP1*^−/−^ mice is presumably due in part to defective NF-κB activation and increased cell death[@R17], the mechanism that underlies the developmental defect of *FADD*^−/−^ mice has remained elusive.

Developmental retardation of *FADD*^−/−^ mouse is apparent at embryonic day (E)11.5 to 13.5 ([Fig. S1a-b](#SD11){ref-type="supplementary-material"}). Histological analysis revealed extensive necrotic cell death and cell loss in *FADD*^−/−^ embryos ([Fig. 1a](#F1){ref-type="fig"}). Absence of FADD sensitizes human Jurkat T lymphoma cells to tumor necrosis factor (TNF)-induced necrosis[@R11]-[@R12]. Furthermore, *FADD*^−/−^ mouse embryonic fibroblasts (MEFs) were hypersensitive to reactive oxygen species (ROS)-induced necrosis[@R18]. In contrast, necrosis induced by ROS was blocked in *RIP1*^−/−^ MEF cells. Examination of wild type (*WT*) E12.5 embryos showed that RIP1 was expressed at low levels while RIP3 was readily detected in multiple tissues including the nervous system, heart and lung (Fig. [1a](#F1){ref-type="fig"} and [S2](#SD12){ref-type="supplementary-material"}). Interestingly, RIP1 expression is highly elevated in *FADD*^−/−^ embryos ([Fig. 1a](#F1){ref-type="fig"}). Furthermore, punctate RIP3 staining was observed in cells of *FADD*^−/−^ embryos, which is indicative of RIP3 aggregation and activation[@R14]. These results indicate that induction of RIP1 expression might play a role in the necrosis observed in *FADD*^−/−^ embryos.

To investigate a potential *in vivo* molecular interplay between FADD- and RIP1-mediated signaling, we crossed the RIP1 knockout alleles into *FADD*^−/−^ mice. Strikingly, *FADD*^−/−^*RIP1*^−/−^ double knockout (*DKO*) embryos were detected at E14.5 at the expected Mendelian frequencies ([Table 1](#T1){ref-type="table"}, Fig. [1b](#F1){ref-type="fig"} and [S1c-f](#SD11){ref-type="supplementary-material"}). In sharp contrast to the highly deformed E14.5 *FADD*^−/−^ embryos, E14.5 *DKO* embryos were indistinguishable from wild type control embryos ([Fig. 1b](#F1){ref-type="fig"}). *DKO* embryos of normal morphology were also found at later gestation stages E15.5, E16.5, E17.5 and E18.5 at the expected Mendelian frequencies ([Fig. S1c](#SD11){ref-type="supplementary-material"} and [Table 1](#T1){ref-type="table"}). Importantly, live *DKO* neonates were also detected at birth ([Fig. S1d](#SD11){ref-type="supplementary-material"}). No *FADD*^−/−^ embryos were detected at E15.5 or later stages. Histological examination did not reveal obvious defects in *RIP1*^−/−^ and *DKO* E18.5 embryos ([Fig. S3](#SD13){ref-type="supplementary-material"}). Postnatal monitoring was performed to determine the survival of *DKO* mice. Among the 104 postnatal mice analyzed (\>0 day, [Table 1](#T1){ref-type="table"}), 30 died within 4 days after birth, which contain 6 *DKO* and 19 *RIP1*^−/−^ genotypes. No death was observed after postnatal day 4 and *DKO* mice were not present in the remaining 74 mice that survive beyond 3 weeks ([Table 1](#T1){ref-type="table"}). These results demonstrate that RIP1 deficiency fully restore embryonic development of *FADD*^−/−^ mice. However, loss of FADD does not prevent neonatal lethality of *RIP1*^−/−^ mice. ROS is an important effector mechanism for necrotic cell death. *FADD*^−/−^ MEFs were hypersensitive to ROS-induced death ([Fig. S4a-b](#SD14){ref-type="supplementary-material"}). In contrast, *RIP1*^−/−^ MEFs were highly resistant to ROS-induced necrosis[@R18]. Addition of the RIP1-specific inhibitor necrostatin-1 (Nec-1)[@R19] greatly reduced ROS-hypersensitivity in *FADD*^−/−^ MEFs ([Fig. S4a-b](#SD14){ref-type="supplementary-material"}). Importantly, *DKO* MEFs were resistant to ROS-induced death. Collectively, these results indicate that FADD deficiency primes embryonic cells to ROS- and RIP1-dependent necrosis, which might cause embryonic lethality.

While important at early hematopoietic stages [@R20], FADD plays a minor role in post lineage commitment lymphopoiesis [@R4],[@R6]-[@R7]. Although *RIP1*^−/−^ neonates contain normal thymocyte numbers[@R16], *RIP1*^−/−^ fetal liver cells failed to reconstitute the peripheral T cell compartment[@R17]. The rescue of embryonic development in *DKO* mice prompted us to examine whether a similar FADD-RIP1 interaction might regulate lymphocyte development. To this end, we adoptively transferred fetal liver cells containing hematopoietic progenitor cells into immunodeficient NSG recipient mice. In agreement with previous results[@R17], NSG chimeras reconstituted with *RIP1*^−/−^ fetal liver cells contained dramatically reduced CD4^+^CD8^+^ double positive immature and CD4^+^ or CD8^+^ single positive mature thymocytes ([Fig. 2a](#F2){ref-type="fig"}). In contrast, the thymic population profile of *DKO* fetal liver cell chimeras was similar to that of the wild type control thymus ([Fig. 2a](#F2){ref-type="fig"}). Reconstitution of the peripheral lymphoid compartment by *DKO* fetal liver cells was apparent, as indicated by the spleen sizes of the recipients of *DKO* fetal liver cells, which was similar to the size of the control spleens receiving wild type fetal liver cells ([Fig. S5a](#SD2){ref-type="supplementary-material"}). In contrast, the spleen of *RIP1*^−/−^ chimeras was smaller than that of wild type or *DKO* chimeras. Flow cytometric analyses showed that *RIP1*^−/−^ chimeras contained few CD3^+^ T cells in the periphery (Fig. [2b](#F2){ref-type="fig"} and [S5b-c](#SD2){ref-type="supplementary-material"}). In contrast, *DKO* chimeras contained significantly higher numbers of T cells in the spleen, lymph nodes, and blood (Fig. [2b](#F2){ref-type="fig"} and [S5b-c](#SD2){ref-type="supplementary-material"}). Similarly, FADD deficiency partially rescued *RIP1*^−/−^ B cell development ([Fig. S5c](#SD2){ref-type="supplementary-material"}). *RIP1*^−/−^ thymocytes were readily killed by treatments with anti-Fas antibodies or TNF ([Fig. 2c-d](#F2){ref-type="fig"}). Interestingly, *DKO* thymocytes were highly resistant to these death stimuli. Although FADD deficiency fully reversed the hypersensitivity to Fas- and TNFα-induced killing, it only partially corrected the NF-κB activation defect in *RIP1*^−/−^ T cells, B cells and MEFs ([Fig. 2e-g](#F2){ref-type="fig"}). These results suggest that the partial rescue of lymphocyte development in the *DKO* chimeras is due to inhibition of FADD-mediated apoptosis rather than rescue of NF-κB activation.

Although T cell-specific deletion of FADD had no effect on thymic development, the resulting mature *FADD*^−/−^ T cells were highly defective in TCR-induced proliferation[@R6] ([Fig. 3a](#F3){ref-type="fig"}). When compared to *FADD*^−/−^ and *WT* controls, *DKO* T cells stimulated through the TCR/CD28 exhibited a remarkable rescue in their proliferative responses ([Fig. 3a](#F3){ref-type="fig"} and [Table S1a](#SD6){ref-type="supplementary-material"}). When transferred to *TCRαβ*^−/−^ hosts, *DKO* T cells were functionally competent to expand and produce IFNγ in response to challenge with Pichinde virus (PV) ([Fig. 3b](#F3){ref-type="fig"}). Acute CD8^+^ T cell responses to the immunodominant epitope NP38 and subdominant epitope NP205 were similar between *WT* and *DKO* donor cells ([Fig. 3b](#F3){ref-type="fig"}). Moreover, challenge of wild type hosts adoptively transferred with *DKO* lymphocytes with lymphocytic choriomenigitis virus (LCMV) showed that the *DKO* T cells could generate a productive anti-viral response to the immunodominant epitope NP396 ([Fig. S6a](#SD3){ref-type="supplementary-material"}). Collectively, these results indicate that RIP1-dependent necrosis underlies the defective proliferation in *FADD*^−/−^ T cells and that inactivation of RIP1 restores the proliferative capacity of *FADD*^−/−^ T cells.

Although FADD does not play a significant role in BCR- or CD40-induced proliferation responses, it is required for TLR3 and TLR4 signaling in B cells[@R7]. Consistent with these observations, *WT, RIP1*^−/−^, *FADD*^−/−^ and *DKO* B cells responded similarly to stimulation with anti-IgM or anti-CD40 antibodies ([Fig. S6b](#SD3){ref-type="supplementary-material"} and data not shown). In contrast to the rescue of T cell proliferation, *DKO* B cells remained defective in proliferative responses to the TLR3 and TLR4 agonists poly IC and LPS, respectively (Fig. [3c](#F3){ref-type="fig"}, [S6c](#SD3){ref-type="supplementary-material"} and [Table S1b](#SD6){ref-type="supplementary-material"}). The differential effect of RIP1 deletion on *FADD*^−/−^ T and B cell proliferation was confirmed with the RIP1-specific inhibitor Nec-1 ([Fig. S6d-e](#SD3){ref-type="supplementary-material"}). Although caspase inhibition did hamper LPS-induced B cell proliferation ([Fig. S7a-b](#SD4){ref-type="supplementary-material"}), RIP1 cleavage, which inactivates the pro-necrotic activity of RIP1, was only observed in TCR-treated T cells, but not LPS-induced B cells or ROS-treated MEFs ([Fig. S8a-c](#SD5){ref-type="supplementary-material"}). Therefore, the FADD-RIP1 axis is preferentially required for controlling proliferation in T cells, but not in B cells.

The current study demonstrates that absence of RIP1 restored normal embryogenesis of *FADD*^−/−^ mice, and FADD deficiency partially corrects the developmental defect in *RIP1*^−/−^ T cells. This finding provides compelling genetic evidence that a critical *in vivo* role for FADD during embryogenesis is to inhibit RIP1-mediated necrosis. In T cells, RIP1 is required to help suppress FADD-mediated apoptosis. Interestingly, *caspase 8*^−/−^ mice exhibited embryonic and T cell defects similar to that of *FADD*^−/−^ mice[@R4]-[@R5],[@R21]. Moreover, Nec-1 rescued the proliferative defect of *caspase 8*^−/−^ and *FADD*^−/−^ T cells[@R22]-[@R23]. Hence, FADD and caspase 8 likely act in concert to keep RIP1-mediated necrosis in check by cleavage and inactivation of RIP1. Such regulatory mechanism is crucial to ensure proper embryogenesis and to prevent abortive expansion of T cells during immune responses. Our results also reveal an unexpected role for RIP1 to keep FADD-mediated apoptosis at bay during T cell development. This regulation is not entirely dependent on RIP1-mediated activation of the NF-κB pathways, unlike that proposed previously[@R16]-[@R17]. The reduced NF-κB activation had no major effect on *DKO* T cell proliferations. In addition to lymphocytes, impairment of the NF-κB pathway is also present in *RIP1*^−/−^ and *DKO* MEFs and likely other cell types, which might lead to postnatal lethality as seen in *RIP1*^−/−^ and *DKO* mice. In summary, our results reveal a complex functional interaction between FADD and RIP1 that is context- and cell type-dependent.

###### Methods summary

Heterozygous *FADD*^+/−^ mutant mice have been described[@R4]. Heterozygous *RIP1*^+/−^ mutant mice[@R16] were provided by Dr. M. Kelliher and crossed into *FADD*^+/−^ mice. Timed pregnancy was set up with the resulting *FADD*^+/−^*RIP1*^+/−^ mouse intercrosses. Embryos were isolated and genotyped by PCR using tissue genomic DNA templates and confirmed by western blots. Fetal liver cells were isolated from E14.5 embryos and adoptively transferred into irradiated (200 RAD) NSG (NOD.Cg-*Prkdc^scid^ Il2rg^tm1Wjl^*/SzJ) mice purchased from The Jackson Laboratory. All animal studies were approved by Institutional Animal Care and Use Committees. Ten to 12 weeks post transfer, cells were isolated from the indicated organs and were analyzed by flow cytometry. T cells and B cells were purified from the spleen and lymph nodes by high-speed sorting and proliferative responses were analyzed as described previously[@R6]-[@R7]. *FADD*^−/−^ mutant T cells and B cells were isolated by sorting from T cell-specific and B cell-specific *FADD*^−/−^ mice as described previously[@R6]-[@R7]. Western blotting was performed according to standard protocols. For embryonic cell death assays, primary MEFs were prepared following the NIH 3T3 protocol. *FADD*^−/−^ MEFs were prepared from E8.5 embryos and *DKO* MEFs from E14.5MEFs. MEF cells were cultured in complete DMEM to 80% confluence, and treated with 0.5 mM H~2~O~2~ with or without Nec-1 (50 μM) for 12 h, and cell death was determined by propidium iodide staining and flow cytometry. Images were taken by using a Nikon inverted light microscope. For virus infections, after adoptive transfer of lymphocytes, mice were challenged with 5 × 10^4^ pfu of LCMV or 1 × 10^7^ pfu of PV. Peptide specific CD8 T cell responses were measured 8 days after infection by intracellular IFNγ staining.
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Online-only Methods {#S2}
===================

Reagents {#S3}
--------

Antibodies were purchased from the following vendors: RIP1 (BD Pharmingen), RIP3 (ProSci), caspase 8 (Axxora), phospho-p65 (Cell Signaling), CD3 (BD Biosciences), CD28 (BD Biosciences), and strepavidin (BD Biosciences). Antibodies used in immunophenotyping were purchased from BD Biosciences or eBioscience or BioLegend. Rabbit anti-FADD antibody were generated in house. Necrostatin-1 and zVAD-fmk were purchased from Axxora.

Mouse genetic analysis {#S4}
----------------------

Mating of *FADD*^+/−^*RIP1*^+/−^ double heterozygous mice was set up at evening. Female mice were examined in the early morning and embryos were designated E0.5 on the day the vaginal plug was detected. E11.5 to E18.5 embryos were isolated from pregnant mice and genomic DNA was extracted from embryo tissues upon digestion with protease K in an SDS containing lysis buffer. Genotyping was performed by PCR using allele-specific primers. 5′-TGCGCCGACACGATCTACTG-3′ and 5′-AGCTGTAGGCTTGTCAGGGTGTTTC -3′ were used for the detection of the FADD wild type allele; 5′-ACTGTAGTGCCCAGCAGAGACCAGC -3′ and 5′-CGCTCGGTGTTCGAGGCCACACGC -3′ for the FADD knock out allele; 5′-TGTGTCAAGTCTCCCTGCAG-3′ and 5′-CACGGTCCTTTTGCCCTG-3 for the RIP1 *WT* allele; and 5′-CTGCTAAAGCGCATGCTC-3′ and 5′-CACGGTCCTTTTGCCCTG-3 for the *RIP1* knock out allele. Presence and absence of the FADD and RIP1 protein was confirmed by western blotting using anti-FADD and anti-RIP1 (BD Pharmingen) antibodies. For postnatal analysis, pregnant females were closely monitored around the time of delivery (after 18.5 days post coitum), by checking at least twice daily. Neonates were either euthanized at birth for genotyping or monitored for survival up to 6 months. Dead mice were immediately removed for genotyping.

Histological analysis and immunohistochemistry {#S5}
----------------------------------------------

Embryos were fixed in 10% buffered formalin overnight. After dehydration in 70% and increasing concentrations of ethanol, embryos were embedded in paraffin. Embryo sections were prepared and standard H&E staining performed. Immunohistochemistry was performed using anti-RIP1 (H207, Santa Cruz) and anti-RIP3 (ProSci) antibodies at 1:200 dilution, followed by incubation with ImmPress anti-rabbit peroxidase (Vector Lab). Signals were developed with 3,3′-Diaminobenzidine (5 min) and Enhancer (DAKO) for 2 min. Sections were then counterstained with hematoxylin.

Lymphocyte immunophenotyping {#S6}
----------------------------

Lymphocytes were isolated from spleen, thymus, lymphocyte nodes and blood. Red blood cells were lysed using the ACK lysis buffer and single cell suspension was prepared, stained for cell surface markers following standard protocols, and data acquisition was performed using a Coulter XL cytometer. Flow cytometric data were analyzed with the FlowJo software (Treestar, San Carlos, CA).

Cell death analysis {#S7}
-------------------

Thymocytes were isolated from the E18.5 embryos and resuspended in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics. Cells were then seeded (1 × 10^5^/well) into 96-well flat bottom plates with various concentrations of anti-Fas antibodies (Jo2; BD Pharmingen) or recombinant mouse TNF-α (Biosource/Invitrogen) in the presence of 30 μg/ml cycloheximide (Sigma-Aldrich). Cell death was determined by propidium iodide (PI) staining and flow cytometry 12-16 h post stimulation.

Lymphocyte activation and western blot analysis {#S8}
-----------------------------------------------

Peripheral T cells and B cells were purified from the spleen and lymphoid nodes using EasySep Isolation reagent (StemCell Technologies) or high speed sorting. Purified T cells were stimulated with biotinylated anti-CD3 antibodies (10μg/ml) and anti-CD28 antibodies (2 μg/ml) by crosslinking with streptavidin (10 μg/ml) for the indicated times at 37 °C. In some experiments, cells were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies. Purified B cells were stimulated with 10 μg/ml LPS for the indicated times at 37°C. Where indicated, cells were pre-incubated with 50 μM zVAD-fmk or 10 μM necrostatin-1 before stimulation. Cells were washed once in ice cold PBS and lysed with ice-cold RIPA lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 1 mM phenylmethyl sulfonyl fluoride (PMSF) and a protease inhibitor cocktail (Roche). Protein was separated on 10% SDS/PAGE then transferred onto nitrocellulose membrane, blocked with 5% milk in TBST, incubated overnight at 4°C with primary Abs. Blots were washed 3 times with TBST and incubated in HRP-conjugated second antibody per manufacturer's recommendations. The Western Lighting Chemiluminescence Reagent Plus (PerkinElmer) or ThermoScientific West Pico chemiluminescence reagents were used to detect signals on x-ray films (Kodak).

Cell culture and proliferation assays {#S9}
-------------------------------------

Purified T cells and B cells were cultured in RPMI 1640 (Mediatech, Herndon, VA) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 1mM glutamine, 5 μM β-mercaptoethanol (Sigma, St. Louis, MO), and 10% FBS (HyClone Laboratories, Logan, UT). Cells were cultured at 37 °C in a 5% CO~2~ incubator. B cells were cultured with the indicated concentrations of LPS, poly IC (Sigma-Aldrich, St. Louis, MO), goat-anti-mouse IgM (F~(ab')2~ μ chain, Jackson ImmunoResearch, West Grove, PA) for 48 h. T cells were stimulated with various concentration of plate-bound anti-CD3 antibodies in 96 well plates in the presence of anti-CD28 (200ng/ml) antibodies for 48 hours. Incorporated \[^3^H\]-thymidine was measured using a Wallac beta counter (PerkinElmer, Wellesley, MA). To determine cell division, cell proliferation measured by dilution of CellTracer Violet dye (Invitrogen) was performed as per the manufacturer's instructions.

Virus infection {#S10}
---------------

Ten to twenty millions wild type or *DKO* total splenocytes were injected via the tail vein to wild type Ly5.1 congenic hosts. For injection into *TCR*αβ^−/−^ hosts, 2 × 10^6^ cells were injected. Eighteen hours later, mice were infected with 5 × 10^4^ pfu of lymphocytic choriomenigitis virus (Armstrong strain) or 1 × 10^7^ pfu of Pichinde virus (strain AN3739) intraperitoneally. Eight days post-infection, splenocytes were isolated and stimulated with the indicated viral peptide antigens for 5 hours or anti-CD3 antibody for 4 hours. Production of IFNγ was examined by intracellular FACS staining on a LSRII flow cytometer (BD Biosciences).

![RIP1 deficiency rescues *FADD*^−/−^ mice from embryonic necrosis and lethality\
**a**, *FADD*^−/−^ embryos exhibit massive necrosis and altered RIP1 and RIP3 expression. E12.5 wild type (*WT*, top panels) or *FADD*^−/−^ embryos (bottom panels) were fixed in formalin. Left panels of hematoxylin and eosin (H&E) staining show extensive cell loss and pyknotic nuclei in the *FADD*^−/−^ fetal liver. Middle and right panels indicate staining for RIP1or RIP3. **b**, E14.5 *DKO* embryos appear normal, contrasting the defective *FADD*^−/−^ embryos.](nihms-268440-f0001){#F1}

![FADD deficiency partially corrects the *RIP1*^−/−^ T cell developmental defect by blocking apoptosis\
Lymphocytes (**a-b)** in the chimeras of the indicated genotypes were analyzed. E18.5 fetal thymocytes of the indicated genotypes were treated with anti-Fas antibodies (**c**) or TNFα (**d**) and death responses determined 12 hours post stimulation. Error bars represent mean ± SEM of triplicates. T cells (**e**) and B cells (**f)** from NSG chimeras of the indicated genotypes were stimulated with anti-CD3 and anti-CD28 antibodies or with LPS, respectively. MEFs were stimulated with TNFα (**g)**. NF-κB activation was indicated by the induction of p65 phosphorylation. β-actin, loading controls.](nihms-268440-f0002){#F2}

![RIP1 deficiency rescues the *FADD*^−/−^ T cell proliferation defect\
**a**, T cells of the indicated wild type and chimera genotypes were stimulated with anti-CD3 and anti-CD28 antibodies. Proliferation was measured by \[^3^H\]-thymidine incorporation. **b**, Splenocytes of the indicated genotypes were transferred into *TCRαβ*^−/−^ hosts and challenged with Pichinde virus (PV). Acute responses of the donor CD8 T cells to the indicated epitopes were determined. Anti-CD3 antibodies were used as control. **c,** B cells of the indicated genotypes were stimulated with LPS and proliferation was measured as in (**a**). Results shown (**a** and **c**) are mean ± SEM of triplicates.](nihms-268440-f0003){#F3}

###### Genetic analysis of FADD and RIP1 deficiency in mice

Timed pregnancy analyses were set up to determine the frequencies of each genotype of offspring from intercrosses of *FADD*^+/−^*RIP1*^+/−^ mice. The actual (shaded) and expected numbers of each or groups of genotypes were shown. Neonates were sacrificed and analyzed at birth (0 day) or monitored for survival for up to 6 month (\>0 days). Numbers of *DKO* embryos or neonates were in bold. Postnatal *RIP1*^−/−^ and *DKO* neonates (\>0 days) died within 4 days after birth.

  ----------------------------------------------------------------------------------
  Genotype               FADD     +/+ or +/−   +/+ or +/−   −/−      −/−     Total
  ------------- -------- -------- ------------ ------------ -------- ------- -------
  E14.5-18.5\   Actual   102      45           17           **14**   178     
  embryos                                                                    

  Expected      100      33       33           11                            

                                                                             

  At or\        Day 0    Actual   26           4            0        **1**   31
  after\                                                                     
  birth                                                                      

  Expected      17       6        6            2                             

                                                                             

  \>day 0       Actual   79       19           0            **6**    104     

  Expected      59       20       20           7                             
  ----------------------------------------------------------------------------------
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